Pre-Market Review
No Coronavirus Vaccine Yet

Posted by James Hughes -
Scope Markets


Markets in Asia followed on from markets on Wall Street and lost ground. This was amid doubts about progress in the development of a Coronavirus vaccine to tackle the COVID-19 outbreak. Stocks on Wall Street turned negative towards the end of Thursday’s session. All happened after a report showed a potential vaccine had failed to help Coronavirus patients.

The markets’ sensitivity to any news about a Coronavirus cure reflects the growing unease about the lockdown. Also, the realisation that lockdown and primarily social distancing measures will need to be in place for in not all then most of 2020 keeps uncertainty floating. It could be that anything pointing to the virus staying with us for longer to potentially impact the stock markets.

Business activity took a hit and shows no signs of picking up as lockdown continues to hit each economy. Data out of Europe and the US yesterday showed that production, supply chains, and spending are under serious pressure.

US to pump more financial aid into the economy

The news comes as the US House of Representatives passed another $480 billion in stimulus for the US economy. This takes the overall aid packages introduced by the US government to well over $3trillion. This comes on the same day that European Central Bank President Christine Lagarde launched a scathing attack on EU leaders. The ECB President said that leaders had done “too little too late’ in agreeing on aid for the Eurozone economy. She also warned that the lack of action could well now see GDP in the Eurozone fall by 15%.

It comes after the EU agreed on a €2 trillion financial fund. However, its release is delayed until the summer.

There is no doubt that the Euro and the European Union are fighting for survival. The Euro bloc has shown itself inadequate in dealing with a crisis. The Eurozone failed to recover properly from any of the three major crisis it has already faced in its short life. With anti-European sentiment growing throughout Europe, there could be some challenging times and tough questions asked in the coming months.

Yesterday’s initial jobless claims showed that more than 4 million more Americans have claimed unemployment benefits in the last week. In total, more than 26 million have now lost their jobs in the previous 5 weeks. There are aspects of the economy that will suffer, but unemployment is vital for economic recovery. The numbers worsen with every week, and with every week the financial hole grows deeper.

Share this article:

Disclaimer: The article above does not represent investment advice or an investment proposal and should not be acknowledged as so. The information beforehand does not constitute an encouragement to trade, and it does not warrant or foretell the future performance of the markets. The investor remains singly responsible for the risk of their conclusions. The analysis and remark displayed do not involve any consideration of your particular investment goals, economic situations, or requirements.

Funding Methods

Scope Markets
Scope Markets
Scope Markets
Scope Markets
Scope Markets
Scope Markets
Scope Markets
Scope Markets

Awards

Scope Markets
Scope Markets
Scope Markets

Scope Markets offers institutional and retail trading services to businesses and traders worldwide. Our top management team has more than 20 years of experience in the industry, and we are proud of the solid partnerships we build over the years. Whether it's a business or individual, Scope Markets has a wide range of trading solutions that are compliant, flexible, cost-efficient, innovative, and place the client first.

Contact Us

Registered address:
5 Cork Street, Belize City, Belize C.A.

Email:
[email protected]

Tel:
+44 2030 516959

Risk Disclaimer

Please note that forex trading and trading in other leveraged products involves a significant level of risk and is not suitable for all investors. Trading in financial instruments may result in losses as well as profits and your losses can be greater than your initial invested capital. Before undertaking any such transactions, you should ensure that you fully understand the risks involved and seek independent advice if necessary. Please read and ensure you fully understand our Risk Disclosure.

Legal Information

Scope Markets Ltd is a company registered under Belize with Registration Number 145,138. Scope Markets Ltd is authorized and regulated by the International Financial Services Commission of Belize (“IFSC”) under the license numbers IFSC/60/373/TS/20 and IFSC/60/373/BCA/20. The registered address of Scope Markets Ltd is, 5 Cork Street, 1708 Belize City, Belize.

Restricted Regions

Scope Markets does not offer its services to the residents of certain jurisdictions such as EU Member States, Iceland, Norway, Liechtenstein, Afghanistan, Democratic People's Republic of Korea, Ghana, Iran (Islamic Republic of), Iraq, Libya, Mongolia, Myanmar, Nicaragua, Panama, Somalia, Syrian Arab Republic, Uganda, United States of America, Yemen, Zimbabwe and Canada. Please check Restricted Countries.

This website uses cookies to provide you with the very best experience and to know you better. By visiting our website with your browser set to allow cookies, you consent to our use of cookies as described in our Privacy Policy.

© Copyright 2020 Scope Markets. All Rights Reserved.